D. Ross Sibson

2.0k total citations
39 papers, 1.6k citations indexed

About

D. Ross Sibson is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, D. Ross Sibson has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in D. Ross Sibson's work include Breast Cancer Treatment Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Molecular Biology Techniques and Applications (5 papers). D. Ross Sibson is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Molecular Biology Techniques and Applications (5 papers). D. Ross Sibson collaborates with scholars based in United Kingdom and United States. D. Ross Sibson's co-authors include Michael P.A. Davies, Philip S. Rudland, C Jarvis, J P Sloane, Angela Platt‐Higgins, Roger Barraclough, Dong L. Barraclough, Balvinder Shoker, Carol Walker and Dun Liu and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

D. Ross Sibson

37 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ross Sibson United Kingdom 21 846 667 478 430 266 39 1.6k
Francesco Schittulli Italy 24 976 1.2× 817 1.2× 728 1.5× 393 0.9× 145 0.5× 75 1.9k
Klaus‐Jürgen Winzer Germany 16 1.1k 1.3× 739 1.1× 570 1.2× 278 0.6× 188 0.7× 47 2.0k
Jalila Adnane United States 18 1.4k 1.7× 939 1.4× 394 0.8× 233 0.5× 248 0.9× 23 2.1k
Rebecca E. Schweppe United States 25 1.2k 1.5× 765 1.1× 360 0.8× 285 0.7× 149 0.6× 48 2.3k
Todd G. Kroll United States 19 1.5k 1.8× 715 1.1× 573 1.2× 499 1.2× 139 0.5× 23 2.8k
Frédérique Spyratos France 24 878 1.0× 660 1.0× 788 1.6× 280 0.7× 102 0.4× 41 1.7k
Chiyomi Egawa Japan 20 740 0.9× 628 0.9× 302 0.6× 471 1.1× 274 1.0× 69 1.4k
J. Teague United Kingdom 6 1.4k 1.6× 458 0.7× 623 1.3× 449 1.0× 96 0.4× 7 2.0k
Isabel Chu United States 11 1.1k 1.3× 1.0k 1.5× 346 0.7× 183 0.4× 267 1.0× 12 1.8k
S. G. Hilsenbeck United States 10 1.2k 1.4× 1.5k 2.2× 703 1.5× 580 1.3× 159 0.6× 16 2.4k

Countries citing papers authored by D. Ross Sibson

Since Specialization
Citations

This map shows the geographic impact of D. Ross Sibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ross Sibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ross Sibson more than expected).

Fields of papers citing papers by D. Ross Sibson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ross Sibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ross Sibson. The network helps show where D. Ross Sibson may publish in the future.

Co-authorship network of co-authors of D. Ross Sibson

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ross Sibson. A scholar is included among the top collaborators of D. Ross Sibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ross Sibson. D. Ross Sibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussain, Syed A., Daniel H. Palmer, Wing‐Kin Syn, et al.. (2017). Gene expression profiling in bladder cancer identifies potential therapeutic targets. International Journal of Oncology. 50(4). 1147–1159. 21 indexed citations
2.
Dhanda, Jagtar, Asterios Triantafyllou, Triantafillos Liloglou, et al.. (2014). SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma. British Journal of Cancer. 111(11). 2114–2121. 48 indexed citations
3.
Shaw, Elisabeth J., Brian Haylock, David Husband, et al.. (2011). Gene expression in oligodendroglial tumors. Cellular Oncology. 34(4). 355–367. 11 indexed citations
4.
Noon, Aidan P., Radosław Polański, Helen Kalirai, et al.. (2011). Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy. British Journal of Urology. 109(8). 1250–1257. 28 indexed citations
5.
Arya, Aditya, Asem Elfert, Richard Eccles, et al.. (2010). Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53. British Journal of Cancer. 103(2). 186–195. 54 indexed citations
7.
Innes, Helen, Dun Liu, Roger Barraclough, et al.. (2006). Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. British Journal of Cancer. 94(7). 1057–1065. 99 indexed citations
8.
Davies, Michael P.A., et al.. (2004). Correlation of mRNA for oestrogen receptor beta splice variants ERβ1, ERβ2/ERβcx and ERβ5 with outcome in endocrine-treated breast cancer. Journal of Molecular Endocrinology. 33(3). 773–782. 33 indexed citations
9.
O'Neill, P A, Abeer M. Shaaban, Christopher R. West, et al.. (2004). Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27. British Journal of Cancer. 90(1). 182–188. 35 indexed citations
10.
Davies, Michael P.A., P A O'Neill, Helen Innes, & D. Ross Sibson. (2004). Hypersensitive K303R oestrogen receptor-α variant not found in invasive carcinomas. Breast Cancer Research. 7(1). R113–8. 13 indexed citations
11.
Simpson, Peter T., Balvinder Shoker, Roger Barraclough, et al.. (2003). Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer. International Journal of Experimental Pathology. 84(4). 173–184. 7 indexed citations
12.
Sibson, D. Ross & Michael P. Starkey. (2003). Increasing the Average Abundance of Low-Abundance cDNAs by Ordered Subdivision of cDNA Populations. Humana Press eBooks. 69. 13–32. 2 indexed citations
13.
Iqbal, Mussawar, Balvinder Shoker, Christopher S. Foster, et al.. (2002). Molecular and genetic abnormalities in radial scar. Human Pathology. 33(7). 715–722. 15 indexed citations
14.
Liu, Dun, Philip S. Rudland, D. Ross Sibson, & Roger Barraclough. (2002). Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells. British Journal of Cancer. 87(4). 423–431. 44 indexed citations
15.
Walker, Carol, Michael P.A. Davies, Fiona E. M. Gibbs, et al.. (2001). Characterisation of molecular alterations in microdissected archival gliomas. Acta Neuropathologica. 101(4). 321–333. 27 indexed citations
16.
Shoker, Balvinder, et al.. (2001). Immunodetectable cyclin D1is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. British Journal of Cancer. 84(8). 1064–1069. 47 indexed citations
17.
Sibson, D. Ross & Fiona E. M. Gibbs. (2001). Molecular indexing of human genomic DNA. Nucleic Acids Research. 29(19). e95–e95. 1 indexed citations
18.
Liu, Dun, Philip S. Rudland, D. Ross Sibson, Angela Platt‐Higgins, & Roger Barraclough. (2000). Expression of calcium-binding protein S100A2 in breast lesions. British Journal of Cancer. 83(11). 1473–1479. 88 indexed citations
19.
Walker, Carol, et al.. (2000). Molecular genetic analysis of archival gliomas using diagnostic smears. Neuropathology and Applied Neurobiology. 26(5). 441–447. 6 indexed citations
20.
Shoker, Balvinder, C Jarvis, Robert B. Clarke, et al.. (2000). Abnormal regulation of the oestrogen receptor in benign breast lesions. Journal of Clinical Pathology. 53(10). 778–783. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026